Singapore legislation

Regulation 47

of Health Products (Therapeutic Products) Regulations 2016

Regulation 47

Transfer of therapeutic products by specified healthcare service licensees without wholesaler’s licence

Amended byS 436/2023 wef 26/06/2023S 811/2023 wef 18/12/2023S 811/2023 wef 18/12/2023

Subregulation 2

A specified healthcare service licensee (other than an outpatient dental service licensee, outpatient medical service licensee or outpatient renal dialysis licensee) (called in this paragraph A) may, in the case of a therapeutic product compounded by A under regulation 46(1) at any approved permanent premises, temporary premises or approved conveyance, transfer A’s stock of the therapeutic product at the approved permanent premises, temporary premises or approved conveyance (as the case may be) to any of the following without holding a wholesaler’s licence:

(a)

[Deleted by S 811/2023 wef 18/12/2023](b)another approved permanent premises, temporary premises or approved conveyance of A;

(c)

any approved permanent premises, temporary premises or approved conveyance of another specified healthcare service licensee.

Subregulation 3

A specified healthcare service licensee who is an outpatient dental service licensee, outpatient medical service licensee or outpatient renal dialysis service licensee (called in this paragraph B) may, in the case of a therapeutic product compounded by B under regulation 46(1) at any approved permanent premises, temporary premises or approved conveyance, transfer B’s stock of the therapeutic product at the approved permanent premises, temporary premises or approved conveyance (as the case may be) to any of the following without holding a wholesaler’s licence, if the approval of the Authority has been obtained under regulation 46(5) for the transfer:

(a)

[Deleted by S 811/2023 wef 18/12/2023](b)any approved permanent premises of B;

(c)

any approved permanent premises of another specified healthcare service licensee.

Subregulation 4

Amended byS 436/2023 wef 26/06/2023S 811/2023 wef 18/12/2023

A specified healthcare service licensee (called in this paragraph C) may, in the case of a therapeutic product that is imported by C under regulation 51 or imported by a licensed importer under regulation 58(1)(f), transfer C’s stock of the therapeutic product to another specified healthcare service licensee without holding a wholesaler’s licence.